posted on 2020-11-09, 10:53authored bySimin Arshi, Mehran Nozari-Asbemarz, Edmond Magner
Biocatalysts provide a number of advantages such as high selectivity, the ability to operate under mild reaction conditions and availability from renewable resources that are
of interest in the development of bioreactors for applications in the pharmaceutical and
other sectors. The use of oxidoreductases in biocatalytic reactors is primarily focused on
the use of NAD(P)-dependent enzymes, with the recycling of the cofactor occurring via an
additional enzymatic system. The use of electrochemically based systems has been limited. This review focuses on the development of electrochemically based biocatalytic reactors.
The mechanisms of mediated and direct electron transfer together with methods of
immobilising enzymes are briefly reviewed. The use of electrochemically based batch and
flow reactors is reviewed in detail with a focus on recent developments in the use of high
surface area electrodes, enzyme engineering and enzyme cascades. A future perspective on
electrochemically based bioreactors is presented.